Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
38,385,136
-
Share change
-
+1,363,571
-
Total reported value
-
$736,980,157
-
Put/Call ratio
-
74%
-
Price per share
-
$19.20
-
Number of holders
-
90
-
Value change
-
+$29,552,695
-
Number of buys
-
56
-
Number of sells
-
36
Institutional Holders of ODONATE THERAPEUTICS INC - COM (ODTC) as of Q4 2020
As of 31 Dec 2020,
ODONATE THERAPEUTICS INC - COM (ODTC) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,385,136 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, BOXER CAPITAL, LLC, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, BlackRock Inc., DRIEHAUS CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, VANGUARD GROUP INC, Samsara BioCapital, LLC, and MORGAN STANLEY.
This page lists
90
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.